Centessa Pharmaceuticals

Performance

About Centessa Pharmaceuticals

Centessa Pharmaceuticals is a biotechnology company focused on developing transformative neuroscience medicines, with an asset-centric approach and pipelines targeting sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders. The company emphasizes patient-centric mission and has programs such as Orexin Receptor 2 agonists, including the ORX750 program, supported by its LockBody technology platform. Headquartered with operations in the United States, Centessa pursues innovative research and drug development through a collaboration-driven model and ongoing clinical development. The website highlights its leadership in neuroscience, patient resources, and investor information.